New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy

New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy

For decades, intensive chemotherapy (IC) has been considered the best therapeutic option for treating acute myeloid leukemia (AML), with no curative option available for patients who are not eligible for IC or who have had failed IC. Over the last few years, several new drugs have enriched the thera...

Full description

Bibliographic Details
Main Authors: Fabio Andreozzi, Fulvio Massaro, Sebastian Wittnebel, Chloé Spilleboudt, Philippe Lewalle, Adriano Salaroli
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
acute myeloid leukemia
immunotherapy
target therapy
venetoclax
Online Access:https://www.mdpi.com/1422-0067/23/7/3887

Similar Items

Similar Items